Felicia is Director of Moderna’s Regional Research Centre and Strategic Alliances in Melbourne, leading mRNA related R&D strategy, partnerships, and ecosystem development across Australia and the Indo Pacific. With more than 20 years’ experience across government, industry, and research, she has advanced Australia’s health security and sovereign capability in medical countermeasures. She established Australia’s national MCM program at the Defence Science and Technology Group and concurrently led Health Security Systems Australia at DMTC. She has advised governments on pandemic preparedness, including the US National Security Council, and served on the Prime Minister’s Science and Industry Technical Advisory Group during COVID 19. She holds a PhD in Biotechnology, a Master of Intellectual Property Law, and a Bachelor of Science with Honours, and is a non-executive director of M:MBio and ThirtyFiveBio.